Karyopharm Therapeutics Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 14/05/2026 | Sep 2025Filed 03/11/2025 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 14/05/2026 | Sep 2024Filed 03/11/2025 | Jun 2024Filed 11/08/2025 | Mar 2024Filed 12/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $33 | $35 | $44 | $38 | $30 | $39 | $43 | $33 | |
| −$67 | −$22 | −$33 | −$37 | −$23 | −$32 | $24 | −$37 | |
| −$2.32 | −$1.24 | −$3.82 | −$4.32 | −$2.77 | −$3.85 | −$2.97 | −$4.85 |
Trend